The publications on this site are part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Companies

Search All Companies »

Find a Company by Name

View All Companies

All
Industries

Biotechnology

Email Alert | RSS Feed

AcelRx Pharmaceuticals Inc. / See Company Profile

Financing / AcelRx secures $25mm debt facility from Oxford Finance / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 6, 2019

Financing / AcelRx brings in $37.6mm through FOPO / Strategic Transactions / Deal Date: Nov. 1, 2018 / Publish Date: Nov. 16, 2018

Financing / AcelRx FOPO nets $21.8mm / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 17, 2018

EpimAb Biotherapeutics Inc. / See Company Profile

Financing / Series B round brings in $74mm for EpimAb / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 5, 2019

Financing / EpimAb Biotherapeutics closes $25mm Series A round / Strategic Transactions / Deal Date: Apr. 1, 2017 / Publish Date: Apr. 28, 2017

Alliance / EpimAb and Kymab enter into bispecific antibody cross-licensing deal / Strategic Transactions / Deal Date: Oct. 1, 2016 / Publish Date: Oct. 18, 2016

Myovant Sciences Ltd. / See Company Profile

Financing / Myovant nets $117.5mm through public offering / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: Jun. 3, 2019

Financing / Public offering nets $74.7mm for Myovant / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 16, 2018

Financing / Myovant secures equity/debt financing commitments up to $140mm; initially gets $33mm / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 17, 2017


Medical Devices

Email Alert | RSS Feed

MiMedx Group Inc. / See Company Profile

Financing / MiMedx secures $75mm loan / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 13, 2019

Acquisition / MiMedx divests Stability Biologics / Strategic Transactions / Deal Date: Aug. 1, 2017 / Update Date: Oct. 1, 2017

Acquisition / MiMedx pays cash and stock for Stability / Strategic Transactions / Deal Date: Jan. 1, 2016 / Publish Date: Jan. 14, 2016

Cardiac Science Corp. / See Company Profile

Acquisition / Zoll buys Cardiac Science / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 11, 2019

Acquisition / Cytocare spins out Cardiac Science to shareholders / Strategic Transactions / Deal Date: Jul. 1, 1991 / Publish Date: Apr. 8, 2016

Acquisition / Cardiac Science divests its diagnostic cardiology line to Mortara Instrument / Strategic Transactions / Deal Date: Apr. 1, 2013 / Publish Date: May 21, 2013

iCAD Inc. / See Company Profile

Financing / Public offering nets $8.5mm for iCAD / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 14, 2019

Financing / iCAD secures $13mm credit facility with SVB and gets access to $10mm up front / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 11, 2017

Financing / Public offering nets $28.6mm for iCAD / Strategic Transactions / Deal Date: Mar. 1, 2014 / Publish Date: Mar. 13, 2014


In Vitro Diagnostics

Email Alert | RSS Feed

Qiagen NV / See Company Profile

Alliance / Inovio, Qiagen pen companion diagnostics deal for VGX3100 HPV vaccine / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: Jun. 14, 2019

Acquisition / Qiagen buys STAT-Dx for $191mm / Strategic Transactions / Deal Date: Jan. 1, 2018 / Publish Date: May 25, 2018

Alliance / Oxford Immunotec, Qiagen settle patent litigation / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 20, 2017

Veracyte Inc. / See Company Profile

Financing / Public offering nets $138mm for Veracyte / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 7, 2019

Alliance / J&J, Veracyte ally in lung cancer diagnostics / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 15, 2019

Financing / Public offering nets $55.4mm for Veracyte / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 27, 2018


Pharmaceuticals

Email Alert | RSS Feed

Brickell Biotech Inc. / See Company Profile

Acquisition / Brickell, Vical reverse merge to create company focused on Brickell's dermatology pipeline / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 4, 2019

Financing / Brickell enters $25mm financing agreement with NovaQuest / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 4, 2019

Alliance / Brickell licenses RORy inhibitors from Orca / Strategic Transactions / Deal Date: Nov. 1, 2015 / Publish Date: Jan. 19, 2016

Lung Therapeutics Inc. / See Company Profile

Financing / Lung Therapeutics gets $36mm via Series C / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 5, 2019

Financing / Lung Therapeutics closes $14.3mm Series B / Strategic Transactions / Deal Date: Jun. 1, 2017 / Publish Date: Jun. 7, 2017

Financing / Lung Therapeutics closes first tranche of Series A / Strategic Transactions / Deal Date: Oct. 1, 2014 / Publish Date: Nov. 3, 2014

Biotechnology

Biotechnology

Email Alert | RSS Feed

AcelRx Pharmaceuticals Inc. / See Company Profile

Financing / AcelRx secures $25mm debt facility from Oxford Finance / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 6, 2019

Financing / AcelRx brings in $37.6mm through FOPO / Strategic Transactions / Deal Date: Nov. 1, 2018 / Publish Date: Nov. 16, 2018

Financing / AcelRx FOPO nets $21.8mm / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 17, 2018

EpimAb Biotherapeutics Inc. / See Company Profile

Financing / Series B round brings in $74mm for EpimAb / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 5, 2019

Financing / EpimAb Biotherapeutics closes $25mm Series A round / Strategic Transactions / Deal Date: Apr. 1, 2017 / Publish Date: Apr. 28, 2017

Alliance / EpimAb and Kymab enter into bispecific antibody cross-licensing deal / Strategic Transactions / Deal Date: Oct. 1, 2016 / Publish Date: Oct. 18, 2016

Myovant Sciences Ltd. / See Company Profile

Financing / Myovant nets $117.5mm through public offering / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: Jun. 3, 2019

Financing / Public offering nets $74.7mm for Myovant / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 16, 2018

Financing / Myovant secures equity/debt financing commitments up to $140mm; initially gets $33mm / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 17, 2017

Medical
Devices

Medical Devices

Email Alert | RSS Feed

MiMedx Group Inc. / See Company Profile

Financing / MiMedx secures $75mm loan / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 13, 2019

Acquisition / MiMedx divests Stability Biologics / Strategic Transactions / Deal Date: Aug. 1, 2017 / Update Date: Oct. 1, 2017

Acquisition / MiMedx pays cash and stock for Stability / Strategic Transactions / Deal Date: Jan. 1, 2016 / Publish Date: Jan. 14, 2016

Cardiac Science Corp. / See Company Profile

Acquisition / Zoll buys Cardiac Science / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 11, 2019

Acquisition / Cytocare spins out Cardiac Science to shareholders / Strategic Transactions / Deal Date: Jul. 1, 1991 / Publish Date: Apr. 8, 2016

Acquisition / Cardiac Science divests its diagnostic cardiology line to Mortara Instrument / Strategic Transactions / Deal Date: Apr. 1, 2013 / Publish Date: May 21, 2013

iCAD Inc. / See Company Profile

Financing / Public offering nets $8.5mm for iCAD / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 14, 2019

Financing / iCAD secures $13mm credit facility with SVB and gets access to $10mm up front / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 11, 2017

Financing / Public offering nets $28.6mm for iCAD / Strategic Transactions / Deal Date: Mar. 1, 2014 / Publish Date: Mar. 13, 2014

In Vitro
Diagnostics

In Vitro Diagnostics

Email Alert | RSS Feed

Qiagen NV / See Company Profile

Alliance / Inovio, Qiagen pen companion diagnostics deal for VGX3100 HPV vaccine / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: Jun. 14, 2019

Acquisition / Qiagen buys STAT-Dx for $191mm / Strategic Transactions / Deal Date: Jan. 1, 2018 / Publish Date: May 25, 2018

Alliance / Oxford Immunotec, Qiagen settle patent litigation / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 20, 2017

Veracyte Inc. / See Company Profile

Financing / Public offering nets $138mm for Veracyte / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 7, 2019

Alliance / J&J, Veracyte ally in lung cancer diagnostics / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 15, 2019

Financing / Public offering nets $55.4mm for Veracyte / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 27, 2018

Pharmaceuticals

Pharmaceuticals

Email Alert | RSS Feed

Brickell Biotech Inc. / See Company Profile

Acquisition / Brickell, Vical reverse merge to create company focused on Brickell's dermatology pipeline / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 4, 2019

Financing / Brickell enters $25mm financing agreement with NovaQuest / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 4, 2019

Alliance / Brickell licenses RORy inhibitors from Orca / Strategic Transactions / Deal Date: Nov. 1, 2015 / Publish Date: Jan. 19, 2016

Lung Therapeutics Inc. / See Company Profile

Financing / Lung Therapeutics gets $36mm via Series C / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 5, 2019

Financing / Lung Therapeutics closes $14.3mm Series B / Strategic Transactions / Deal Date: Jun. 1, 2017 / Publish Date: Jun. 7, 2017

Financing / Lung Therapeutics closes first tranche of Series A / Strategic Transactions / Deal Date: Oct. 1, 2014 / Publish Date: Nov. 3, 2014

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel